4.7 Article

Efficacy of short novel antimicrobial and anti-inflammatory peptides in a mouse model of methicillin-resistant Staphylococcus aureus (MRSA) skin infection

期刊

DRUG DESIGN DEVELOPMENT AND THERAPY
卷 8, 期 -, 页码 1979-1983

出版社

DOVE MEDICAL PRESS LTD
DOI: 10.2147/DDDT.S72129

关键词

antimicrobial peptides; MRSA; lysostaphin; skin infection; mice

资金

  1. Egyptian Cultural and Educational Bureau (ECEB) in Washington, DC, USA

向作者/读者索取更多资源

The therapeutic efficacy of two novel short antimicrobial and anti-inflammatory peptides (RR and RRIKA) was evaluated in a mouse model of staphylococcal skin infection. RR (2%) and RRIKA (2%) significantly reduced the bacterial counts and the levels of proinflammatory cytokines, tumor necrosis factor (TNF)-alpha, and interleukin (IL)-6, in methicillin-resistant Staphylococcus aureus USA 300-0114 skin lesions. Furthermore, the combined therapy of RRIKA (1%) and lysostaphin (0.5%) had significantly higher antistaphylococcal and anti-inflammatory activity compared to monotherapy. This study supports the potential use of these peptides for topical treatment of methicillin-resistant Staphylococcus aureus skin infections.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Microbiology

In Vivo Antibacterial Activity of Acetazolamide

Nader S. Abutaleb, Ahmed Elkashif, Daniel P. Flaherty, Mohamed N. Seleem

Summary: Acetazolamide showed promising inhibitory effects against enterococci and outperformed linezolid in VRE mouse models, suggesting it as a potential treatment option for VRE infections.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)

Article Biochemistry & Molecular Biology

Repurposing FDA-approved sulphonamide carbonic anhydrase inhibitors for treatment of Neisseria gonorrhoeae

Nader S. Abutaleb, Ahmed E. M. Elhassanny, Alessio Nocentini, Chad S. Hewitt, Ahmed Elkashif, Bruce R. Cooper, Claudiu T. Supuran, Mohamed N. Seleem, Daniel P. Flaherty

Summary: Ethoxzolamide exhibits potent anti-gonococcal activity and warrants further investigation as an effective agent against Neisseria gonorrhoeae.

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2022)

Article Chemistry, Medicinal

In Vitro and In Vivo Activity of (Trifluoromethyl)pyridines as Anti- Chlamydia trachomatis Agents

Mohamed A. Seleem, Nicholas A. Wood, Amanda J. Brinkworth, Srikanth Manam, Rey A. Carabeo, Ashlesh K. Murthy, Scot P. Ouellette, Martin Conda-Sheridan

Summary: This research identified compounds with enhanced anti-chlamydial potency, which were not harmful to mammalian cells and did not affect other common bacterial strains. Molecule 20 showed the highest activity, and in combination with the antibiotic azithromycin, acted synergistically to inhibit chlamydial growth.

ACS INFECTIOUS DISEASES (2022)

Article Chemistry, Medicinal

Mechanistic Studies andIn VivoEfficacy of an Oxadiazole-Containing Antibiotic

George A. Naclerio, Nader S. Abutaleb, Kenneth Onyedibe, Caroline Karanja, Hassan E. Eldesouky, Hsin-Wen Liang, Alexandra Dieterly, Uma K. Aryal, Tiffany Lyle, Mohamed N. Seleem, Herman O. Sintim

Summary: This study elucidates the mechanism by which HSGN-94 inhibits LTA biosynthesis and demonstrates its efficacy in reducing MRSA load and pro-inflammatory cytokines in a mouse model. HSGN-94 shows promise as a potential drug for staphylococcal infections.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Multidisciplinary Sciences

Auranofin exerts antibacterial activity against Neisseria gonorrhoeae in a female mouse model of genital tract infection

Ahmed E. M. Elhassanny, Nader S. Abutaleb, Mohamed N. Seleem

Summary: This study demonstrated the in vivo activity of auranofin against Neisseria gonorrhoeae, proving its potential as a promising antimicrobial agent.

PLOS ONE (2022)

Article Biochemistry & Molecular Biology

Structure-activity relationship studies for inhibitors for vancomycin-resistant Enterococcus and human carbonic anhydrases

Weiwei An, Katrina J. Holly, Alessio Nocentini, Ryan D. Imhoff, Chad. S. Hewitt, Nader S. Abutaleb, Xufeng Cao, Mohamed N. Seleem, Claudiu T. Supuran, Daniel P. Flaherty

Summary: This paper discusses the inhibition mechanism and effects of the inhibitor acetazolamide (AZM) and its analogs against vancomycin-resistant enterococci (VRE), as well as the research methods related to binding to different enzymes and selectivity.

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2022)

Article Multidisciplinary Sciences

Discovery of a novel natural product inhibitor of Clostridioides difficile with potent activity in vitro and in vivo

Rusha Pal, Mohamed N. Seleem

Summary: This study reports a novel natural product scaffold as a potential therapeutic choice for C. difficile infection. Six compounds with potent activity against C. difficile were identified and found to be non-toxic to human cells. These compounds also inhibited the production of key toxins and exhibited superior bactericidal activity compared to standard treatment. In a mouse model, one compound showed 100% protection against clinical manifestations of the disease.

PLOS ONE (2022)

Article Chemistry, Medicinal

Design, Biological Evaluation, and Computer-Aided Analysis of Dihydrothiazepines as Selective Antichlamydial Agents

Luana Janaina de Campos, Mohamed A. . Seleem, Jiachen Feng, Kelly Mari Pires de Oliveira, Joao Victor de Andrade dos Santos, Shivdeep Hayer, Jonathan B. Clayton, Sharvath Kathi, Derek J. Fisher, Scot P. Ouellette, Martin Conda-Sheridan

Summary: Chlamydia trachomatis (CT) is the main cause of sexually transmitted bacterial disease in the United States. The lack of drug selectivity poses a challenge for current antichlamydial pharmacotherapy. By studying the disruption of CT-ClpXP by dihydrothiazepines, we synthesized a library of these compounds and evaluated their antichlamydial activity. We also demonstrated the inhibitory effect of our lead compound on ClpX ATPase activity and its promising selectivity, cytotoxicity, mutagenic potential, and in vitro stability. We generated a 2D QSAR model to aid in the identification of more potent antichlamydial molecules. This study suggests that dihydrothiazepines are a promising starting point for the development of selective antichlamydial drugs.

JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Chemistry, Medicinal

Structural Characterization of Thiadiazolesulfonamide Inhibitors Bound to Neisseria gonorrhoeae a-Carbonic Anhydrase

Anil Kumar Marapaka, Alessio Nocentini, Molly S. Youse, Weiwei An, Katrina J. Holly, Chittaranjan Das, Ravi Yadav, Mohamed N. Seleem, Claudiu T. Supuran, Daniel P. Flaherty

Summary: Drug-resistant Neisseria gonorrhoeae poses a serious threat to public health. The research team solved the structure of carbonic anhydrase inhibitors bound to the essential alpha-carbonic anhydrase isoform from N. gonorrhoeae, revealing differences compared to the human enzyme.

ACS MEDICINAL CHEMISTRY LETTERS (2023)

Article Microbiology

Atazanavir Resensitizes Candida auris to Azoles

Yehia Elgammal, Ehab A. Salama, Mohamed N. Seleem

Summary: We have identified atazanavir as a potent drug that can resensitize clinical isolates of C. auris to azole antifungal drugs. Atazanavir is capable of inhibiting efflux pumps, glucose transport, and ATP synthesis in all tested isolates of C. auris. Furthermore, the combination of itraconazole with atazanavir-ritonavir significantly reduces the burden of azole-resistant C. auris in murine kidneys.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2023)

Article Chemistry, Medicinal

Evaluation of 1,3,4-Thiadiazole Carbonic Anhydrase Inhibitors for Gut Decolonization of Enterococci

Nader S. Abutaleb, Annadka Shrinidhi, Aloka B. Bandara, Mohamed N. Seleem, Daniel P. Flaherty

Summary: Vancomycin-resistant enterococci (VRE) are drug-resistant pathogens that require new therapeutic approaches. Decolonization of VRE from carriers can reduce the risk of infections in healthcare settings. This study found that carbonic anhydrase inhibitors showed better efficacy in VRE gut decolonization compared to linezolid.

ACS MEDICINAL CHEMISTRY LETTERS (2023)

Article Materials Science, Biomaterials

Biocompatibility and Safety Assessment of Combined Topical Ozone and Antibiotics for Treatment of Infected Wounds

Alexander Roth, Akshay Krishnakumar, Robyn R. R. McCain, Murali Kanaan Maruthamuthu, MacKenzie McIntosh, Yue Xiang Chen, Abigail D. D. Cox, Amber S. S. Jannasch, Juliane Nguyen, Mohamed N. N. Seleem, Rahim Rahimi

Summary: Recent studies have demonstrated that combining gaseous ozone and antibiotics through portable systems is a promising approach to eradicating antibiotic-resistant Gram-negative bacteria in wound infections. An optimized combination delivery of 4 mg/h of ozone and 200 μg/cm2 of topical antibiotics was found to effectively eliminate bacteria in just 6 hours, with minimal cytotoxicity to human fibroblast cells. Furthermore, in vivo studies on pig models showed no signs of adverse effects even after 5 days of continuous administration.

ACS BIOMATERIALS SCIENCE & ENGINEERING (2023)

Article Infectious Diseases

Lopinavir and ritonavir act synergistically with azoles against Candida auris in vitro and in a mouse model of disseminated candidiasis

Ehab A. Salama, Hassan E. Eldesouky, Yehia Elgammal, Nader S. Abutaleb, Mohamed N. Seleem

Summary: This study found that the HIV protease inhibitors lopinavir and ritonavir, when used in combination with azole antifungals, can effectively treat Candida auris infections that have developed resistance to antifungal drugs. The study demonstrated the synergistic interactions between lopinavir, ritonavir, and azole antifungals, and the potential of ritonavir to interfere with fungal efflux pumps. In a mouse model, ritonavir enhanced the activity of lopinavir and significantly reduced the fungal burden in the kidneys.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2023)

Article Immunology

Colonization efficiency of multidrug-resistant Neisseria gonorrhoeae in a female mouse model

Babatomiwa Kikiowo, Aloka B. Bandara, Nader S. Abutaleb, Mohamed N. Seleem

Summary: Gonococcal resistance to antibiotics is increasing, necessitating the development of novel drugs. In this study, streptomycin-resistant mutants of azithromycin and ceftriaxone-resistant Neisseria gonorrhoeae were constructed and their colonization efficacy in mouse models was determined, providing a basis for evaluating the effectiveness of new agents.

PATHOGENS AND DISEASE (2023)

Article Biochemistry & Molecular Biology

Expanding the structure-activity relationships of alkynyl diphenylurea scaffold as promising antibacterial agents

Hanzada T. Nour T. El-Din, Mohamed M. Elsebaie, Nader S. Abutaleb, Ahmed M. M. Kotb, Ahmed S. Attia, Mohamed N. Seleem, Abdelrahman S. Mayhoub

Summary: In this study, a series of structurally related acetylenic-diphenylurea derivatives carrying the aminoguanidine moiety were tested for their antibacterial efficacy against multidrug-resistant Gram-positive clinical isolates. Compound 18 showed superior bacteriological characteristics compared to the lead compound I. In addition, compound 18 demonstrated excellent in vitro antibacterial profile, high tolerability towards mammalian cells, and significant effectiveness in controlling MRSA infection in an animal model.

RSC MEDICINAL CHEMISTRY (2023)

暂无数据